ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 623

Epigenetic Studies in Maternally Versus Paternally Transmitted Psoriatic Disease

Darren D. O'Rielly1, Remy Pollock2, Yuhua Zhang3, Nayef Al Ghanim1, Sean Hamilton1, Dafna D. Gladman2, Vinod Chandran2, Rose Ardern1, Guangju Zhai3 and Proton Rahman1, 1Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada, 2University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3Discipline of Genetics, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Epidemiologic methods, methylation and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology

Session Type: Abstract Submissions (ACR)

Background/Purpose: Epidemiological studies have noted excess paternal transmission in psoriasis and psoriatic arthritis. To date, there has been no molecular explanation to account for this observation. Differential methylation patterns have long been implicated as a potential mechanism to account for excess paternal transmission. In this pilot study, we investigated the differential methylation pattern among paternally and maternally transmitted PsA.

Methods:   Twenty-four (24) patients with maternally transmitted PsA were compared with 24 paternally transmitted PsA cases. For maternally transmitted PsA, the proband’s mother had either psoriasis or PsA, and for paternally transmitted PsA,  the proband’s father had either psoriasis or PsA. Genome-wide DNA methylation profiling was performed on all these 48 samples by using Illumina HumanMethylation450k Beadchip, which measures up ~480,000 different CpG sites per sample and covers 96% of RefSeq genes. The methylation level at each CpG site was measured by β values varying from 0 (no methylation) to 1 (100% methylation). 

Results: Maternally transmitted PsA cases were predominantly females (19/24) with mean age of onset of PsA at 30.6 years. For paternally transmitted PsA, there were slightly more females (13/24) and age of onset of PsA was 22.2 years. Methylation data were normalized using BMIQ method and no batch effects were detected by PCA analysis. Methylation analysis was performed on 382,024 of the 485,512 CpG sites after filtering and revealed 90 significant CpG sites (p<0.05). The three most significant CpG sites were hypermethylated regions located on chromosome 8 that did not reside on or adjacent to a gene, with p values ranging from 9x10-7 to 5×10-6. Many genes of interest based on current understanding of psoriatic disease were identified including hypermethylation of CPG sites on MICA (diff 10.22%; p=0.014), IRIF1 (diff 10.3%; p=0.016), PSORS1C3 (diff 11.1%; p=0.005); and TNFS4 (diff 15.2%; 0.004). Excess hypomethylation at CPG sites was noted on PSORS1C1 (18.9% diff. p=0.027).

Conclusion: These preliminary results demonstrate that the global DNA methylation pattern in paternally transmitted PsA differs from maternally transmitted PsA. High priority candidate regions and genes identified in this study need further validation.


Disclosure:

D. D. O’Rielly,
None;

R. Pollock,
None;

Y. Zhang,
None;

N. Al Ghanim,
None;

S. Hamilton,
None;

D. D. Gladman,

Abbvie, Amgen, Celgene, Janssen, Pfizer, UCB,

2,

Abbvie, Amgen, BMS, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, UCB,

5;

V. Chandran,
None;

R. Ardern,
None;

G. Zhai,
None;

P. Rahman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epigenetic-studies-in-maternally-versus-paternally-transmitted-psoriatic-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology